Technical Analysis for MXC - MGC Pharmaceuticals Limited
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Very Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Support | Bullish | 0.00% | |
| Boomer Buy Setup | Bullish Swing Setup | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| 20 DMA Support | Bullish | 0.00% | |
| 50 DMA Support | Bullish | 0.00% | |
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| Outside Day | Range Expansion | 0.00% |
Get a Trading Assistant
MGC Pharmaceuticals Limited Description
MGC Pharmaceuticals Limited, together with its subsidiaries, produces and supplies phytocannabinoid derived medicines in Australia and Slovenia. The company's products under development include CannEpil, which is in Phase IIb clinical trial for the treatment in children and adolescents with refectory epilepsy; CogniCann that is in Phase II clinical trial to treat dementia and Alzheimer's diseases; and ArtemiC, which is in Phase II clinical trial for the treatment COVID-19. It has strategic collaborative partnership agreements Epilepsy Action Australia, Royal Melbourne Institute of Technology, the University of Notre Dame in Western Australia, as well as the National Institute of Biology & University Medical Centre, Ljubljana Slovenia. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is headquartered in West Perth, Australia.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Pharmaceutical Industry Clinical Trial Pharmaceutical Industry In China Health Sciences Clinical Research Dementia Alzheimer's Diseases Design Of Experiments Clinical Pharmacology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 40.0 |
| 52 Week Low | 0.05 |
| Average Volume | 33,298 |
| 200-Day Moving Average | 13.27 |
| 50-Day Moving Average | 20.08 |
| 20-Day Moving Average | 21.16 |
| 10-Day Moving Average | 21.77 |
| Average True Range | 2.37 |
| RSI (14) | 56.71 |
| ADX | 59.9 |
| +DI | 12.98 |
| -DI | 1.48 |
| Chandelier Exit (Long, 3 ATRs) | 16.90 |
| Chandelier Exit (Short, 3 ATRs) | 26.10 |
| Upper Bollinger Bands | 23.33 |
| Lower Bollinger Band | 18.99 |
| Percent B (%b) | 0.69 |
| BandWidth | 20.50 |
| MACD Line | 0.35 |
| MACD Signal Line | 0.29 |
| MACD Histogram | 0.0556 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 24.70 | ||||
| Resistance 3 (R3) | 24.70 | 23.80 | 24.25 | ||
| Resistance 2 (R2) | 23.80 | 23.11 | 23.80 | 24.10 | |
| Resistance 1 (R1) | 22.90 | 22.69 | 22.90 | 22.90 | 23.95 |
| Pivot Point | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 |
| Support 1 (S1) | 21.10 | 21.31 | 21.10 | 21.10 | 20.05 |
| Support 2 (S2) | 20.20 | 20.89 | 20.20 | 19.90 | |
| Support 3 (S3) | 19.30 | 20.20 | 19.75 | ||
| Support 4 (S4) | 19.30 |
